Yuki Gosei Kogyo

4531.TTSE STANDARDPharmaceutical
Filed as Yuki Gosei Kogyo Co., Ltd. (2022-06–2026-06)
Major holders (5%+) · 0
HolderStakeChangeFiled

No holder currently reports 5% or more.

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 5
-3.03%2025-02-18
Sumitomo Pharma Co., Ltd.2.92%2024-07-17
-1.77%2025-02-18
-0.00%2025-02-18
SUMITOMO CHEMICAL COMPANY, LIMITED0.00%2024-07-17
Ownership history · 8
FiledHolderRatioChangePurpose
2025-02-18-2025-02-180.00%-0.13pp—
2025-02-18-2025-02-181.77%-0.21ppStrategic holding (cross-shareholding)
2025-02-18-2025-02-183.03%no changeStrategic holding (cross-shareholding)
2024-07-29-2024-07-290.13%newPure investment
2024-07-29-2024-07-291.98%newPure investment; Strategic holding (cross-shareholding)
2024-07-29-2024-07-293.03%newStrategic holding (cross-shareholding)
2024-07-17SUMITOMO CHEMICAL COMPANY, LIMITED2024-07-170.00%newBusiness / capital relationship
2024-07-17Sumitomo Pharma Co., Ltd.2024-07-172.92%newBusiness / capital relationship

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.